Brilliant Board Review & CME

🎙️ Episode 34: MS Meds After 55? Time for a Pause ?

Season 1 Episode 34

Send us a text

🧪 Study:

Patients ≥55 with no relapses in 5 yrs and no new lesions in 3 yrs may stop disease-modifying therapy (DMT).

No significant difference in disability progression.

🧩 Clinical Takeaway:

De-escalation strategy in stable MS may reduce cost and side effects.

Still requires close neurology follow-up.